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Background: Plants produce hosts of secondary metabolites that help them fight off infections. However these 
phytochemicals have also been found to inadvertently protect humans against infections and are therefore a current 
subject in bio-prospecting for new therapeutic leads. 
Objective: The aim of this study was to investigate the antibacterial properties of organic solvent root extracts of 
Indigofera lupatana Baker F.  
Methodology: Powdered sample of I. lupatana Baker F. roots were sequentially extracted using hexane, 
dichloromethane and ethyl acetate. The resultant fractions were subjected to anti-bacterial assay. 
Results: The general inhibition by the hexane extract was low. Gram positive bacteria and P. aeruginosa were not 
sensitive to hexane extract. The dichloromethane and ethyl acetate fractions showed marked activity in all tested 
bacteria. Their activities were generally greater against the Gram positive bacteria than Gram negative bacteria They 
were particularly active against B. subtilis.  
Discussion: These results provide a partial justification for traditional usage of Indigofera lupatana Baker F. However, 
further in vivo and cytotoxicity studies are required to establish safety. 
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1. Introduction 
Herbal remedies as cheap alternatives to conventional 
medicine have contributed significantly to rural 
livelihoods. Apart from the traditional healers 
practicing herbal medicine, many people are involved in 
collecting and trading medicinal plants. The World 
Health Organization (WHO) estimates that 80% of the 
world’s population depends on medicinal plants for 
their primary health care (Mothana et al, 2008; Ngoci et 
al, 2011). The use of traditional medicine has been 
explored globally and is widely used in developing 
countries as an alternative or to complement 
conventional medicine (Rates, 2001; Gupta et al, 2010).  
Natural products, either as pure compounds or as 
standardized plant extracts, provide exceptional 
opportunities for new drug leads because of the 
unmatched chemical diversity of naturally derived 
compounds (Cowan, 1999; Parekh and Chanda, 2007; 
Mariita et al, 2010; Ngoci et al, 2011). Scientific interest 
in medicinal plants has burgeoned due to the 
recognized efficacy of plant derived drugs and ever-
present concerns about the side effects of modern 
medicinal substances. This has fuelled the intensive 
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investigation of new molecular structures from the 
plant kingdom as potential medicinal compounds 
(Mariita et al, 2010). As a result, drugs derived from 
unmodified natural products or semi-synthetic drugs 
obtained from natural sources accounted for 78% of the 
new drugs approved by the United States Food and 
Drug Administration (FDA) between 1983 and 1994 
(Suffredini et al, 2006; Ngoci et al, 2011). This 
underscores the importance of screening natural 
products. 
Infectious diseases are a leading cause of human and 
animal mortality. This is further aggravated by the rapid 
development of multi-drug resistance to available anti-
microbial agents (Doughart and Okafor, 2007; Ngoci et 
al, 2011), their limited anti-microbial spectrum, their 
side effects (Huie, 2002), and emergence and re-
emergence of opportunistic infections. Therefore, 
studies aimed at identifying and characterizing of the 
substances that exhibit activity against infectious micro-
organisms, yet showing no cross resistance with 
existing antibiotics, are required (Olila et al, 2001). In 
recent years, pharmaceutical companies have focused 
on developing drugs from natural products that 
promises to counter the limitations of conventional 
antibiotics (Doughart and Okafor, 2007). 
The bio-activity of natural products is due to 
phytochemicals, a group of secondary metabolites often 
elaborated for the plant defense against pests and 
herbivores or to gain an advantage over competing 
agents. These phytochemicals inadvertently also protect 
humans against pathogens (Ngoci et al, 2011). Some 
phytochemicals are known to have antimicrobial 
properties, immune-modulative properties, provide 
nutrition for normal cell health and repairs, inhibit 
carcinogens and act as antioxidants.  
Indigofera lupatana Baker F., locally called ‘mugiti’ by 
the Mbeere community in Kenya, is a woody shrub 
found in Acacia-Combretum ecological zones of Mbeere. 
It is widely used for its perceived medicinal value in 
treating coughs and diarrhea (Riley and Brokensha, 
1988; Ngoci et al, 2011), gonorrhea and pleurisy 
(Kokwaro, 1993; Ngoci et al, 2011).  
There is apparently no documented scientific report on 
anti-microbial properties of this plant. This lack of 
scientific corroboration has often constituted a major 
constraint to the consideration of the use of herbal 
remedies in conjunction with or as an affordable 
alternative to conventional medical treatment (Okeke et 
al, 2001). Knowledge of the chemical constituents of 
plants is desirable not only for the discovery of 
therapeutic agents, but also because such information 
may be important in identifying new sources of 
substances of economic value such as tannins, oils, 
gums, and precursors for the synthesis of complex 
chemical substances. In addition, the knowledge of the 
chemical constituents of plants would further be 
valuable in discovering the actual value of folkloric 
remedies (Mojab et al, 2003). 
This study was therefore undertaken to determine the 
antibacterial properties of hexane, ethyl acetate and 
dichloromethane root extracts of I. lupatana Baker F. 
 
2. Methods 
2.1 Collection and Identification of Plant Samples 
The plant samples for the study were collected from 
Mbeere district, Embu County of Kenya. The plant was 
taxonomically authenticated at the Department of 
Biological Sciences of Egerton University. A voucher 
sample was assigned a reference number (NSN1) and 
banked in the departmental herbarium.  
2.2 Preparation of Indigofera indica root extracts 
The plant roots were separated, washed, cut into small 
pieces, air-dried in the dark to avoid decomposition of 
light sensitive bioactive compounds (Houghton and 
Raman, 1998), at room temperature to a constant 
weight and milled into a powder. The powder was 
extracted sequentially using three organic solvents of 
increasing polarity - hexane, dichloromethane and ethyl 
acetate, in that order - as described below. 
Ground material (150 g) was firstly soaked in the less 
polar hexane for 24 hours at room temperature with 
intermittent shaking followed by decanting and 
filtration by gravity to separate the debris. Fresh 
solvent was replaced and agitated for 10 minutes, 
decanted and filtered. The two volumes were combined 
together and concentrated under reduced pressure and 
the residue allowed to air dry. The process was 
repeated with material agitated in dichloromethane and 
ethyl acetate in the same manner as above (Houghton 
and Raman, 1998; Wojcikowski et al, 2008). 
2.3 Test Micro-organisms 
The following microbial strains were used as test 
cultures: three Gram-positive bacterial species - Bacillus 
subtilis BGA (Merck, Darmstadt, Germany), Bacillus 
cereus ATCC 11778 (Difco Laboratories, Detroit, USA) 
and Staphylococcus aureus ATCC 25923 (KEMRI) - and 
five Gram-negative bacteria - Escherichia coli ATCC 
25922 (KEMRI), Pseudomonas aeruginosa ATCC 27853 
(KEMRI), Salmonella typhimurium ATCC 13311 
(KEMRI), Klebsiella pneumoniae and Proteus mirabilis 
(clinical isolates from KEMRI).  These were maintained 
on nutrient agar slants at 4 °C. 
2.4 Anti-microbial tests 
These were used to evaluate in vitro activity of the 
various extracts.  
Media preparation 
The media was reconstituted using distilled water 
according to the manufacturer’s instructions, sterilized 
by autoclaving at 121 °C for 15 min, and dispensed 
aseptically into Petri dishes (9 cm diameter). A volume 
of between 18-25 ml molten agar was dispensed to 
achieve a depth of between 3-4 mm, and left to solidify 
and then stored in the refrigerator at 4 °C. The 
inoculation plates were air dried with the lids ajar until 
there were no moisture droplets on the petri dish 
surfaces (Collins et al, 1995). 
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Preparation of discs 
Stock solutions of each extract (hexane extract 1.5 g/ml, 
ethyl acetate extract 1.4 g/ml and dichloromethane 
extract 1.0 mg/ml) were prepared in 1% aqueous 
dimethylsulfoxide (DMSO). Working extract solutions 
were prepared by two-fold serial dilutions of each stock 
solution in 1% aqueous DMSO. The aqueous 1% DMSO 
was used as solvent for the extracted samples because it 
is amphipathic, able to diffuse well in the agar and at 
this concentration it is non toxic (Moshi et al, 2006; 
Mbaveng et al., 2008). 
Whatmann filter paper (No. 1) discs of 6 mm diameter 
were made by punching the paper, and the blank discs 
were sterilized in the hot air oven at 160 °C for 1 hr. 
They were then impregnated with 10 μl of the various 
working extract solutions. The discs were dried by 
heating at 50 °C (Ayo et al, 2007).  
Chloramphenicol 30 µg/disc was used as a standard 
drug for positive control (STDb) against bacteria; a disc 
loaded with 10 µl of 1% aqueous DMSO used as a 
negative control (STDa) (Mbwambo et al, 2007; 
Mbaveng et al, 2008). The choice of chloramphenicol 
was based on its properties as a broad spectrum 
antibiotic, a very stable drug under a variety of 
conditions of temperature and humidity, and its low 
toxicity threshold when ingested (Drew et al, 1972).  
Disc diffusion test 
The anti-bacterial activity was assayed by disc diffusion 
method according to Ayo et al, (2007), CLSI (2007) and 
Mbaveng et al, (2008). Nutrient agar was used for sub-
culturing of the test micro-organisms and Mueller 
Hinton agar was used for sensitivity assay (Nguemeving 
et al, 2006). 
The bacterial strains were activated by growing them 
on nutrient agar at 37 °C for 18 - 24 hr. A fresh inoculum 
was developed by suspending activated colonies in 
physiological saline solution (0.85% NaCl). An inoculum 
of bacterial cell suspension of about 1.5 × 106 CFU/ml 
was determined and standardized using a McFarland 
turbidity standard No. 0.5. The suspension was 
authenticated by adjusting the optical density to 0.1 at 
600 nm.  
This suspension was used to aseptically inoculate 
Mueller Hinton agar plates by swabbing the surface. 
Excess liquid was air-dried under a sterile hood. The 
impregnated discs were then planted at equidistant 
points on top of the inoculated agar medium using 
sterile forceps. The inoculated plates were incubated at 
4 °C for 2 hr to allow the pre-diffusion of extracts into 
the media. The plates were then incubated at 37 °C for 
24 hr. Anti-bacterial activity was evaluated by 
measuring the diameter of the zone of inhibition. The 
lowest concentration of the extract that inhibited 
bacterial growth was recorded as the MIC of the extract 
fraction (Mothana et al, 2008). 
2.5 Phytochemical tests 
Phytochemical tests were done to determine the classes 
of compounds present in the various extracts. These 
were identified by characteristic colour changes using 
standard procedures according to Houghton and 
Raman, (1998), Edeoga et al, (2005), Shanmugavalli et 
al, (2009), and Ngoci et al (2011). The results were 
reported as (+ve) for presence, and (-ve) for absence.   
2.6 Statistical analysis 
The test values were expressed as mean ± standard 
error of the mean (SEM).  
3. Results 
The anti-bacterial activity test revealed extracts activity 
against both Gram positive and Gram negative bacteria. 
The activity varied depending with the extract tested, 
extract concentration and the test bacteria. 
The general inhibition by the hexane extract was low, 
with the maximum inhibition (observed against E. coli) 
giving a zone of inhibition of 6.5±0.3 mm at the highest 
concentration tested, and MIC of 750 mg/ml. Gram 
positive bacteria and P. aeruginosa were not sensitive to 
hexane extract. The activity of the hexane extract is 
summarized in Table 1.   
The activity of the dichloromethane extract is 
summarized in Table 2. It showed activity against all 
the strains of bacteria tested, and was most active 
against the Gram positive B. subtilis bacteria, showing a 
zone of inhibition of 28.5 ± 0.3 at the highest 
concentration tested, and an MIC of 31.3 mg/ml. Among 
the Gram negative bacteria, this extract was most active 
against E. coli (zone of inhibition of 21.7 ± 0.7 mm at the 
highest concentration tested, and an MIC of 125). 
The ethyl acetate extract also showed activity against all 
the strains of bacteria tested, and was also most active 
against the Gram positive B. subtilis bacteria, showing a 
zone of inhibition of 26.0 ± 0.3 mm at the highest 
concentration tested, and an MIC of 21.9 mg/ml. Among 
the Gram negative bacteria, this extract was most active 
against P. aeruginosa (zone of inhibition of 21.5 ± 0.9 
mm at the highest concentration tested, and MIC of 175) 
(Table 3). 
The results of the phytochemical testing are shown in 
Table 4. 
4. Discussion 
The plant extracts had broad spectrum activity. They 
inhibited growth of both Gram positive and Gram 
negative bacteria. The inhibition zones increased on 
increasing the concentration of the extract in the discs 
showing a concentration dependent activity and also 
varied with the species of bacteria tested. Although the 
concentrations of the extract fractions were > 100 times 
more than the standard antibiotic used 
(chloramphenicol), they showed notable anti-bacterial 
activity as evidenced by their zones of inhibition. This 
could be due to the fact that the active components in 
the extract comprise only a fraction of the extract used. 
Therefore, the actual concentration of the active 
components in the extract could be much lower. It is 
possible that the active components could show higher 
antibacterial activity than those observed if they were 
isolated and purified. 
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Table 1: Anti-bacterial activity result for the hexane root extract fraction 
Micro organism 
Inhibition zones diameter in mm 
MIC(mg/ml) Extract concentration (µg x 102/disc) 
STDa (STDb 30µg/disc) 150 75 37.5 18.8 9.4 Extract STDb 
Gram negative bacteria 
E. coli 6.5 ± 0.3 0 0 0 0 0 48.3±1.7 750 25 
K. pneumoniae 6.0±0 0 0 0 0 0 37.6 ± 0.8 750 22.5 
P. aeruginosa  0 0 0 0 0 0 24.3 ± 1.3 >750 NT 
P. mirabilis 6.3±0.3 0 0 0 0 0 34.3 ± 1.3 750 NT 
S. typhimurium 6.3±0.3 0 0 0 0 0 29.0 ± 1.5 750 NT 
Gram positive bacteria 
S. aureus 0 0 0 0 0 0 37.3 ± 0.9 >750 31.3 
B. cereus NT NT NT NT NT NT NT NT NT 
B. subtilis NT NT NT NT NT NT NT NT NT 
STDa –Represent 1% DMSO as negative control; STDb – Represents Chloramphenicol as positive control; E – Represents extract 
fraction and NT – Represent not tested. Values are inhibition zones in mm (mean ± SEM; n = 3). 
 
Table 2: Anti-bacterial activity result for the dichloromethane root extract fraction 
Micro organism 
Inhibition zones diameter in mm 
MIC(mg/ml) Extract concentration (µg x 102/disc) 
STDa (STDb 30µg/disc) 100 50 25 12.5 6.3 Extract STDb 
Gram negative bacteria 
E. coli 21.7 ± 0.7 14.0±0.6 11.0±1 0 0 0 48.3±1.0 125 25 
K. pneumoniae 11.4 ± 0.8 7.7±0.3 0 0 0 0 37.6 ± 0.8 250 22.5 
P. aeruginosa  10.0 ± 0.7 8.3±0.3 7.0±0 0 0 0 24.3 ± 1.3 125 NT 
P. mirabilis 10.7 ± 0.7 9.2±0.7 7.0±0.5 0 0 0 34.3 ± 1.3 125 NT 
S. typhimurium 8.3 ± 0.6 0 0 0 0 0 29.0 ± 1.5 500 NT 
Gram positive bacteria 
S. aureus 22.6 ± 1.0 12.4±2.8 0 0 0 0 37.3 ± 0.9 250 31.3 
B. cereus 22.0 ± 0.1 20.5±0.5 17.0±2.0 12.0±0 0 0 22.3 ± 0.8 62.5 NT 
B. subtilis 28.5 ± 0.3 27.5±0.5 21.5±0.5 19.0±0.6 18±0 0 32.6 ± 0.9 31.3 26.3 
STDa –Represent 1% DMSO as negative control; STDb – Represents Chloramphenicol as positive control; E – Represents extract 
fraction and NT – Represent not tested. Values are inhibition zones in mm (mean ± SEM; n = 3). 
The hexane fraction had the lowest activity against the 
test bacteria. This could have been due to absence of 
phytochemicals such as flavonoids, tannins, saponins, 
cardiac glycosides, terpenoids and phenolics (Table 4) 
that have been associated with antimicrobial activity or 
due to antagonistic actions of specific compounds in the 
hexane crude extract (Cowan, 1999; Ogunwenmo et al, 
2007; Al-Bayati and Al-Mola, 2008). 
The dichloromethane fraction showed marked activity 
in all tested bacteria. This activity was probably due to 
phytochemicals detected in the extract fraction such as 
tannins that act by complexing bacterial proteins, 
interfering with bacterial adhesion, inactivating 
enzymes and disrupting bacterial cell membrane 
(Cowan, 1999; Okuda, 2005; Biradar et al, 2007; Samy 
and Gopalakrishnakone, 2008; Kaur and Arora, 2009). 
Also, activity could be due to flavonoids, saponins, 
cardiac glycosides, phytosteroids and terpenoids that 
were detected in the extract and could have been 
responsible for the antibacterial activity (Ngoci et al, 
2011).. 
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Table 3: Anti-bacterial activity result for the ethyl acetate root extract 
Micro 
organism 
Inhibition zones diameter in mm 
MIC(mg/ml) Extract concentration (µg x 102/disc) 
STDa (STDb 30µg/disc) 140 70 35 17.5 8.8 Extract STDb 
Gram negative bacteria 
E. coli 16.3 ± 0.7 14.0±1.0 12.0±0.5 0 0 0 48.3 ± 1.0 175 25 
K. pneumoniae 10.6 ± 0.9 8.0±0.5 0 0 0 0 37.6 ± 0.8 350 22.5 
P. aeruginosa 21.5 ± 0.9 10.0±1.0 7.0±0 0 0 0 24.3 ± 1.3 175 NT 
P. mirabilis 10.4 ± 1.1 6.0±0 0 0 0 0 34.3 ± 1.3 350 NT 
S. typhimurium 17.3 ± 0.3 0 0 0 0 0 29.0 ± 1.5 700 NT 
Gram positive bacteria 
S. aureus 7.0±0.1 0 0 0 0 0 37.3 ± 0.9 700 31.3 
B. cereus 21.2 ± 0.6 19.5±0.5 15.0±1.0 13.5±0.5 8.0±1.7 0 22.3 ± 0.8 43.8 NT 
B. subtilis 26.0 ± 0.3 24.5±0.5 23.0±1.0 21.0±0.6 18±0.5 0 32.6 ± 0.9 21.9 26.3 
STDa –Represent 1% DMSO as negative control; STDb – Represents Chloramphenicol as positive control; E – Represents extract 
fraction and NT – Represent not tested. Values are inhibition zones in mm (mean ± SEM; n = 3) 
 
Table 4: Phytochemical test results 
Phytochemical constituent Hexane extract Dichloromethane extract Ethyl acetate extract 
Alkaloids  -ve -ve -ve 
Flavonoids -ve +ve +ve 
Tannins -ve +ve -ve 
Saponins -ve +ve +ve 
Cardiac glycosides -ve +ve +ve 
Phlobatannins  +ve -ve +ve 
Phytosteroids +ve +ve +ve 
Terpenoids -ve +ve +ve 
Phenolics -ve +ve +ve 
+ve: presence of the tested phytochemicals in the sample extract 
−ve: absence of the tested phytochemicals in the sample extract 
The ethyl acetate fraction showed marked activity in all 
tested bacteria. It was particularly active against P. 
aeruginosa, B. cereus and B. subtilis, with the highest 
sensitivity recorded against B. subtilis. This observed 
antibacterial activity could be due to flavonoids that 
have been shown to act by complexing proteins and 
disrupting membranes (Navarro et al, 2003; Al-Bayati 
and Al-Mola, 2008; Samy and Gopalakrishnakone, 2008; 
Kaur and Arora, 2009), saponins that have been 
demonstrated to act by inhibiting bacterial colonization, 
lowering surface tension of extracellular medium or by 
lysing bacterial membranes (Al-Bayati and Al-Mola, 
2008), phytosteroids and terpenoids that acts by 
disrupting bacterial membrane (Cowan, 1999; Soares et 
al, 2005; Ogunwenmo et al, 2007; Samy and 
Gopalakrishnakone, 2008). Cardiac glycosides and 
phlobatannins that were also detected could be 
responsible for antibacterial activity. 
The bioactivities demonstrated by the different extracts 
may be attributed to the diversity of structures and/or 
the uneven distributions of chemical constituents 
between these extracts. Each extract had a different 
degree of inhibitory activity and specificity against 
bacteria and this could be related to the polarity of the 
extracting solvent (Przybylski et al., 1998). The polar 
solvents extracted phenolics, tannins, flavonoids, 
terpenoids that are responsible for the bioactivity of 
these extracts and could either have exhibited 
synergistic or additive effects when used in their crude 
form (Mohamed et al, 2010). 
Gram positive strains were generally more susceptible 
to the extracts than Gram negative strains. This is in 
agreement with previous reports that plant extracts are 
more active against Gram positive bacteria than Gram 
negative bacteria (Parekh and Chanda, 2006; Mohamed 
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et al, 2010). The higher sensitivity of Gram-positive 
bacteria could be attributed to their outer 
peptidoglycan layer which is not an effective 
permeability barrier as compared to the outer 
phospholipid membranes of Gram-negative bacteria 
(Trombetta et al, 2005; Tomczykowa et al, 2008; Kaur 
and Arora, 2009). 
The present work showed the potential of the tested 
extracts against the causative agents of nosocomial 
infections and morbidity among immune-compromised 
and severely ill patients such as P. aeruginosa and S. 
aureus (Bastos et al., 2009; Kaur and Arora, 2009). 
Infections caused by P. aeruginosa and B. cereus are 
difficult to combat (Aliero and Afolayan, 2005) and 
therefore their susceptibility to the extracts is a pointer 
to extracts’ potential against these bacteria.  
The plant extracts also showed commendable activity 
toward pathogen responsible for the gastrointestinal 
disorders that leads to diarrhea, cholecystitis, and 
urinary tract infections e.g. E. coli, S. typhimurium 
(Moshi et al., 2006; Matasyoh et al., 2007) and this 
partially supports the traditional use of this plant for 
the treatment of diarrhea (Riley and Brokensha, 1988). 
5. Conclusion 
From this study it can be concluded that the Indigofera 
lupatana Baker F. extracts had broad spectrum 
bioactivity as they inhibited both Gram-positive and 
Gram-negative bacteria. This partially supports the 
traditional usage of this plant for therapeutic purposes. 
However further studies on in vivo activity as well as 
determination of cytotoxicity using cell lines needs to be 
undertaken. 
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